Exciting news! The Jhpiego-led, Unitaid-funded AMPLI-PPHI (Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact) project has reached tens of thousands of women with critical drugs to prevent and treat postpartum hemorrhage, a leading cause of maternal deaths worldwide. The project, operating now in four countries — Democratic Republic of Congo, Guinea, India, and Kenya
Geneva/Baltimore, 9 July 2024 – Three critical drugs for preventing and treating postpartum hemorrhage – the leading cause of death in childbirth – have reached women in the Democratic Republic of Congo, Guinea, India and Kenya through a Unitaid-funded, Jhpiego-led program. Postpartum hemorrhage, which is defined as a severe loss of blood after giving birth,
AMPLI – PPHI Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact News To Know: PATH and Jhpiego just launched a call for Expression of Interest (EOI) to identify potential industry partners that can contribute to improving access to life-saving medicines in low- and middle-income countries to prevent and treat postpartum hemorrhage. Manufacturers of misoprostol tablets and tranexamic acid injectables are encouraged to apply! Did you know? Postpartum hemorrhage
